VJOncology is committed to improving our service to you

Share this video  

VJOncology is committed to improving our service to you

VJVirtual | The impact of COVID-19 on clinical research

Melvin L. K Chua • 29 Apr 2020
Head and Neck Cancer

Melvin L.K. Chua, MBBS, FRCR, PhD, National Cancer Center Singapore, Singapore, discusses the impact of COVID-19 on clinical research in patients with head and neck cancers. This interview was recorded via an online conference call with The Video Journal of Oncology (VJOncology).

More from Melvin L. K Chua

10:46
International consortium for COVID-19 paper
Melvin L. K Chua • 29 Apr 2020
11:34
COVID-19: risk of cancer patients to infection
Melvin L. K Chua • 29 Apr 2020

Related Videos

3:08
KEYNOTE-048: pembrolizumab monotherapy for frontline R/M HNSCC
Barbara Burtness
2:00
Durvalumab plus danvatirsen for R/M HNSCC: exciting SCORES data
Ezra Cohen
3:10
The risks of radioactive iodine treatment in thyroid cancer
Remco Molenaar
0:58
Checkpoint inhibitors for head and neck cancer in the definitive setting?
Barbara Burtness
VJOncology VJOncology is intended for Healthcare Professionals only

By choosing to continue, you are confirming that you are a healthcare professional

Sign-up for our Newsletter!

Keep up to date with all the latest news with our monthly newsletter

Subscribe now
The content of VJOncology is intended for healthcare professionals